Early detection, prevention and management of renal failure in liver transplantation

被引:6
作者
Castells, Lluis [1 ,2 ]
Baliellas, Carme [3 ]
Bilbao, Itxarone [4 ]
Cantarell, Carme [5 ]
Maria Cruzado, Josep [6 ]
Esforzado, Nuria [7 ]
Carlos Garcia-Valdecasas, Juan [8 ]
Llado, Laura [9 ]
Rimola, Antoni [10 ]
Seron, Daniel [5 ]
Oppenheimer, Federico [7 ]
机构
[1] Hosp Valle De Hebron, Serv Med Interna Hepatol, Barcelona, Spain
[2] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain
[3] Hosp Univ Bellvitge, Inst Invest Biomed, Serv Aparato Digest, Lhospitalet De Llobregat, Spain
[4] Hosp Valle De Hebron, Unidad Trasplante Hepat, Barcelona, Spain
[5] Hosp Valle De Hebron, Serv Nefrol, Barcelona, Spain
[6] Hosp Univ Bellvitge, Serv Nefrol, Lhospitalet De Llobregat, Spain
[7] Hosp Clin Barcelona, Serv Nefrol, Unidad Trasplante Renal, E-08036 Barcelona, Spain
[8] Hosp Clin Barcelona, Serv Trasplante Hepat, Barcelona, Spain
[9] Hosp Univ Bellvitge, Unidad Cirugia Hepat, Lhospitalet De Llobregat, Spain
[10] Hosp Clin Barcelona, Serv Hepatol, Barcelona, Spain
来源
GASTROENTEROLOGIA Y HEPATOLOGIA | 2014年 / 37卷 / 08期
关键词
Renal failure; Liver transplantation; Everolimus; Mammalian target of rapamycin inhibitors; GLOMERULAR-FILTRATION-RATE; SERUM CYSTATIN-C; STANDARD-DOSE TACROLIMUS; ANTI-THYMOCYTE GLOBULIN; CHRONIC KIDNEY-DISEASE; MYCOPHENOLATE-MOFETIL; CALCINEURIN INHIBITORS; RISK-FACTORS; CYCLOSPORINE NEPHROTOXICITY; EVEROLIMUS MONOTHERAPY;
D O I
10.1016/j.gastrohep.2013.11.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Renal failure is a frequent complication in liver transplant recipients and is associated with increased morbidity and mortality. A variety of risk factors for the development of renal failure in the pre- and post-transplantation periods have been described, as well as at the time of surgery. To reduce the negative impact of renal failure in this population, an active approach is required for the identification of those patients with risk factors, the implementation of preventive strategies, and the early detection of progressive deterioration of renal function. Based on published evidence and on clinical experience, this document presents a series of recommendations on monitoring RE in LT recipients, as well as on the prevention and management of acute and chronic renal failure after LT and referral of these patients to the nephrologist. In addition, this document also provides an update of the various immunosuppressive regimens tested in this population for the prevention and control of post-transplantation deterioration of renal function. (C) 2013 Elsevier Espana, S.L.U. and AEEH y AEG. All rights reserved.
引用
收藏
页码:480 / 491
页数:12
相关论文
共 96 条
[2]  
[Anonymous], ESTUDIO ICEBERG GAST
[3]  
[Anonymous], ACT DON TRASPL CAT I
[4]   ABC OF MONITORING DRUG-THERAPY - AMINOGLYCOSIDE ANTIBIOTICS [J].
ARONSON, JK ;
REYNOLDS, DJM .
BRITISH MEDICAL JOURNAL, 1992, 305 (6866) :1421-1424
[5]   Use of Sirolimus in Liver Transplant Recipients with Renal Insufficiency: A Systematic Review and Meta-Analysis [J].
Asrani, Sumeet K. ;
Leise, Michael D. ;
West, Colin P. ;
Murad, M. Hassan ;
Pedersen, Rachel A. ;
Erwin, Patricia J. ;
Tian, Jianmin ;
Wiesner, Russell H. ;
Kim, W. Ray .
HEPATOLOGY, 2010, 52 (04) :1360-1370
[6]   Rabbit anti-thymocyte globulin in liver transplantation: All that glitters is not gold, but 1000 patients are so many to dazzle [J].
Berenguer, Marina ;
Pons, Jose-Antonio .
LIVER TRANSPLANTATION, 2012, 18 (07) :755-760
[7]   Cystatin C as a marker of renal function immediately after liver transplantation [J].
Biancofiore, G ;
Pucci, L ;
Cerutti, E ;
Penno, G ;
Pardini, E ;
Esposito, M ;
Bindi, L ;
Pelati, E ;
Romanelli, A ;
Triscornia, S ;
Salvadorini, MP ;
Stratta, C ;
Lanfranco, G ;
Pellegrini, G ;
Del Prato, S ;
Salizzoni, M ;
Mosca, F ;
Filipponi, F .
LIVER TRANSPLANTATION, 2006, 12 (02) :285-291
[8]  
Bilbao I, 1998, CLIN TRANSPLANT, V12, P123
[9]   Immunosuppression based on mycophenolate mofetil in stable liver transplanted patients [J].
Bilbao, Itxarone ;
Castells, Luis ;
Rojas, Luis ;
Cancino, Jorge ;
Dopazo, Cristina ;
Castro, Ernest ;
Pou, Leonor ;
Andino, Ricardo ;
Margarit, Carlos .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2006, 6 (13-14) :1977-1983
[10]  
Blaufox MD, 1996, J NUCL MED, V37, P1883